Biomarker tests analyze a patient's underlying biology to help clinicians diagnose disease, monitor progression and identify ...
A new CRISPR-powered light sensor can detect the faintest whispers of cancer in a single drop of blood.
A new light-based sensor can spot incredibly tiny amounts of cancer biomarkers in blood, raising the possibility of earlier and simpler cancer detection. The technology merges DNA nanotechnology, ...
Imagine this: someone you love has just heard the words “you have cancer.” They are meeting with their oncologist – perhaps even me, or one of my colleagues – and come to understand that there is ...
Almost all of us have been touched by cancer at some point in our lives. If we haven’t had it, chances are we know a loved one or a friend who has. When someone dies from cancer, families go through ...
3don MSN
Blood-based tests show strong promise for dementia diagnosis—but population diversity matters
In a study published today, Friday, February 13, 2026, in the journal Nature Aging, researchers show that blood-based ...
Heather Quintana Suchan, a mother living with stage 4 lung cancer, is using her platform to encourage other patients to pursue biomarker testing and genomic profiling early in the diagnostic process, ...
BeiGene is back with a new partnership and oncology campaign to raise awareness about biomarker testing for patients with chronic lymphocytic leukemia (CLL), a blood cancer marked by the ...
In 2020, as many as 5.8 million Americans were living with Alzheimer’s Disease (AD)—a number projected to nearly triple to 14 million people by 2060. 1 As changes in the brain can begin years before ...
PUBLIC LIFE. IOWA CANCER SURVIVORS ARE GATHERING AT THE STATE HOUSE THIS AFTERNOON AS KCCI ETHAN HUMBLE EXPLAINS THEIR MEETING WITH LAWMAKERS TO DISCUSS WHAT CAN BE DONE TO REDUCE THE RISK OF THAT ...
Across all cancer types, less than 50% of patients underwent biomarker testing before first-line treatment. Many patients with advanced cancer do not receive guideline-recommended biomarker testing ...
Mississippi's House Bill 565, known as Jill's Law, aims to provide coverage for biomarker testing to improve cancer treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results